CSI Market
Sign In | Register

Innate Pharma Sa (IPHA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IPHA Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Innate Pharma Sa's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents31.46
Cash & Short-term Investments31.00
Other Current Assets20.85
Total Current Assets52.32
Other Assets, Noncurrent17.93
Total Assets70.25
Liabilities
Other Liabilities, Current37.15
Current Provisions3.90
Total Current Liabilities41.05
Total Long-term Debt0.00
Noncurrent Provisions0.37
Total Liabilities94.55
Stockholders' Equity
Other Equity-39.73
Common Stockholder's Equity-24.31
Total Stockholder's Equity-24.31
Liabilities & Stockholder's Equity70.25
4 historic quarters locked

Sign in to unlock the full Innate Pharma Sa balance sheet history.

Sign In Create Free Account

About Innate Pharma Sa Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001598599-26-000005

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.